The protective role of exercise against age-related neurodegeneration

A Sujkowski, L Hong, RJ Wessells, SV Todi - Ageing Research Reviews, 2022 - Elsevier
Endurance exercise is a widely accessible, low-cost intervention with a variety of benefits to
multiple organ systems. Exercise improves multiple indices of physical performance and …

Mitochondrial dysfunction and oxidative stress in Alzheimer's disease, and Parkinson's disease, Huntington's disease and amyotrophic lateral sclerosis-an updated …

T Alqahtani, SL Deore, AA Kide, BA Shende, R Sharma… - Mitochondrion, 2023 - Elsevier
Misfolded proteins in the central nervous system can induce oxidative damage, which can
contribute to neurodegenerative diseases in the mitochondria. Neurodegenerative patients …

[HTML][HTML] The impact of mitochondrial dysfunction in amyotrophic lateral sclerosis

J Zhao, X Wang, Z Huo, Y Chen, J Liu, Z Zhao, F Meng… - Cells, 2022 - mdpi.com
Amyotrophic lateral sclerosis (ALS) is a rapidly progressive and highly fatal
neurodegenerative disease. Although the pathogenesis of ALS remains unclear, increasing …

[HTML][HTML] Bioactivity of olive oil phenols in neuroprotection

C Angeloni, M Malaguti, MC Barbalace… - International Journal of …, 2017 - mdpi.com
Neurological disorders such as stroke, Alzheimer's and Parkinson's diseases are associated
with high morbidity and mortality, and few or no effective options are available for their …

[HTML][HTML] Amyotrophic lateral sclerosis

LC Wijesekera, P Nigel Leigh - Orphanet journal of rare diseases, 2009 - Springer
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterised by
progressive muscular paralysis reflecting degeneration of motor neurones in the primary …

[HTML][HTML] Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson's, Huntington's …

DB Kell - Archives of toxicology, 2010 - Springer
Exposure to a variety of toxins and/or infectious agents leads to disease, degeneration and
death, often characterised by circumstances in which cells or tissues do not merely die and …

Dexpramipexole versus placebo for patients with amyotrophic lateral sclerosis (EMPOWER): a randomised, double-blind, phase 3 trial

ME Cudkowicz, LH van den Berg, JM Shefner… - The Lancet …, 2013 - thelancet.com
Background In a phase 2 study, dexpramipexole (25–150 mg twice daily) was well tolerated
for up to 9 months and showed a significant benefit at the high dose in a combined …

Mitochondrial dysfunction in ALS

M Cozzolino, MT Carrì - Progress in neurobiology, 2012 - Elsevier
In the present article, we review the many facets of mitochondrial dysfunction in amyotrophic
lateral sclerosis (ALS), a fatal neurodegenerative disease due to loss of upper motor …

Copper at synapse: Release, binding and modulation of neurotransmission

N D'Ambrosi, L Rossi - Neurochemistry international, 2015 - Elsevier
Over the last decade, a piece of the research studying copper role in biological systems was
devoted to unravelling a still elusive, but extremely intriguing, aspect that is the involvement …

Protein folding stress in neurodegenerative diseases: a glimpse into the ER

S Matus, LH Glimcher, C Hetz - Current opinion in cell biology, 2011 - Elsevier
Several neurodegenerative diseases share common neuropathology, primarily featuring the
presence in the brain of abnormal protein inclusions containing specific misfolded proteins …